These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 21146374)
1. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors. Gronier B Eur Neuropsychopharmacol; 2011 Feb; 21(2):192-204. PubMed ID: 21146374 [TBL] [Abstract][Full Text] [Related]
2. Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors. Di Miceli M; Gronier B Psychopharmacology (Berl); 2015 Jun; 232(12):2191-205. PubMed ID: 25572531 [TBL] [Abstract][Full Text] [Related]
3. Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: an electrochemical study in freely-behaving rats. Doherty MD; Gratton A Brain Res; 1996 Apr; 715(1-2):86-97. PubMed ID: 8739626 [TBL] [Abstract][Full Text] [Related]
4. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Berridge CW; Devilbiss DM; Andrzejewski ME; Arnsten AF; Kelley AE; Schmeichel B; Hamilton C; Spencer RC Biol Psychiatry; 2006 Nov; 60(10):1111-20. PubMed ID: 16806100 [TBL] [Abstract][Full Text] [Related]
5. D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of N-methyl-d-aspartate currents in the rat prefrontal cortex. Wirkner K; Krause T; Köles L; Thümmler S; Al-Khrasani M; Illes P Neurosci Lett; 2004 Nov; 372(1-2):89-93. PubMed ID: 15531094 [TBL] [Abstract][Full Text] [Related]
6. Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors. Lane EL; Cheetham S; Jenner P J Pharmacol Exp Ther; 2005 Mar; 312(3):1124-31. PubMed ID: 15542624 [TBL] [Abstract][Full Text] [Related]
7. Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics. Gioanni Y; Thierry AM; Glowinski J; Tassin JP Synapse; 1998 Dec; 30(4):362-70. PubMed ID: 9826228 [TBL] [Abstract][Full Text] [Related]
8. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. Wilens TE J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677 [TBL] [Abstract][Full Text] [Related]
9. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization. Sorg BA; Li N; Wu WR J Pharmacol Exp Ther; 2001 May; 297(2):501-8. PubMed ID: 11303036 [TBL] [Abstract][Full Text] [Related]
11. Dopamine enhances spatiotemporal spread of activity in rat prefrontal cortex. Bandyopadhyay S; Gonzalez-Islas C; Hablitz JJ J Neurophysiol; 2005 Feb; 93(2):864-72. PubMed ID: 15469958 [TBL] [Abstract][Full Text] [Related]
12. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core. Rouillon C; Abraini JH; David HN Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353 [TBL] [Abstract][Full Text] [Related]
13. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats. Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349 [TBL] [Abstract][Full Text] [Related]
14. Essential role of D1 but not D2 receptors in methamphetamine-induced impairment of long-term potentiation in hippocampal-prefrontal cortex pathway. Ishikawa A; Kadota T; Kadota K; Matsumura H; Nakamura S Eur J Neurosci; 2005 Oct; 22(7):1713-9. PubMed ID: 16197511 [TBL] [Abstract][Full Text] [Related]
15. Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. Gamo NJ; Wang M; Arnsten AF J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1011-23. PubMed ID: 20855046 [TBL] [Abstract][Full Text] [Related]
16. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Pan WH; Yang SY; Lin SK Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740 [TBL] [Abstract][Full Text] [Related]
17. Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors. Cheng J; Xiong Z; Duffney LJ; Wei J; Liu A; Liu S; Chen GJ; Yan Z Biol Psychiatry; 2014 Dec; 76(12):953-62. PubMed ID: 24832867 [TBL] [Abstract][Full Text] [Related]
18. cAMP and extracellular signal-regulated kinase signaling in response to d-amphetamine and methylphenidate in the prefrontal cortex in vivo: role of beta 1-adrenoceptors. Pascoli V; Valjent E; Corbillé AG; Corvol JC; Tassin JP; Girault JA; Hervé D Mol Pharmacol; 2005 Aug; 68(2):421-9. PubMed ID: 15890841 [TBL] [Abstract][Full Text] [Related]
19. Methylphenidate amplifies long-term potentiation in rat hippocampus CA1 area involving the insertion of AMPA receptors by activation of β-adrenergic and D1/D5 receptors. Rozas C; Carvallo C; Contreras D; Carreño M; Ugarte G; Delgado R; Zeise ML; Morales B Neuropharmacology; 2015 Dec; 99():15-27. PubMed ID: 26165920 [TBL] [Abstract][Full Text] [Related]
20. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]